Skip to content

Clinical trials

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20122
20141
20152
20161
20171
20211
20222
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Unknown status2
Active, not recruiting1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
Baxalta now part of Shire2
CSL Behring2
Biogen1
Bioverativ, a Sanofi company1
Grifols Therapeutics LLC1
Immunovant Sciences GmbH1
Janssen Research & Development, LLC1
Kite, A Gilead Company1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating18
Autoimmune Diseases2
Autoimmune Diseases of the Nervous System2
Nervous System Diseases2
Peripheral Nervous System Diseases2
Polyradiculoneuropathy2
Demyelinating Diseases1
Diabetes Mellitus1
Immune System Diseases1
Multiple Sclerosis1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.